Medical Oncologist
CION Cancer Clinics
Founder mutations in India: what is known and what is not | CION Cancer Clinics
Genome studies show that many Indian communities carry strong founder effects from centuries of marrying within. Very few cancer founder changes have been confirmed, though. This page sets out what is actually known, why Indian reports are more often uncertain, and why full-gene testing remains the right approach for families in Telangana, Andhra Pradesh and beyond. At CION Cancer Clinics in Hyderabad, our oncologists review your family history with you and guide you to the right genetic counselling and testing.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Are there cancer founder mutations in Indian communities?
- What is actually known about Indian founder changes?
- How would a change be confirmed as an Indian founder change?
- The words you will meet, in plain language
- What we know, and what we do not yet know
- What this page cannot tell you
- Four things families tell us, and what is actually true
- Common questions about founder mutations in India
The short answer
Are there cancer founder mutations in Indian communities?
Almost certainly some exist, but very few have been confirmed. Genome studies show that many Indian communities have strong founder effects, because they married within themselves for centuries. Which of those shared changes involve cancer genes is still being worked out, and the answer is not yet good enough to change how Indian families are tested.
What the genome studies found
A large study of South Asian groups found that many had founder effects as strong as, or stronger than, those in well-known founder populations such as Ashkenazi Jewish and Finnish communities. That makes India one of the most promising places in the world to find community-specific changes. It does not yet tell us which ones matter for cancer.
What that means for your test today
Because no Indian founder panel has been validated, laboratories here read the whole gene rather than checking a short list. That is the right approach. It finds a founder change if there is one, and it finds a private family change too. Once a change is found in your family, relatives can then be tested for that exact change, which is simpler and usually cheaper.
India's founder story is still being written. Your test does not have to wait for it.The evidence so far
What is actually known about Indian founder changes?
Four things can be said with reasonable confidence. Beyond them, most claims run ahead of the evidence.
Strong founder effects are common
Many Indian castes and communities show the genetic signature of a small founding group followed by centuries of marrying within. This is a finding about history, not about disease. It tells researchers where to look, and it explains why a change can be common in one district and almost absent in the next.
Some BRCA changes keep recurring
Indian studies have reported a handful of BRCA1 and BRCA2 changes more than once, including one also known as a founder change abroad. Whether these are true Indian founder changes is not settled. A change can recur simply because that spot in the gene is prone to errors, which is a different thing from a shared ancestor.
A clear example is not about cancer
One community in Andhra Pradesh was found to carry a shared change that makes certain anaesthetic drugs wear off very slowly. It shows how a founder change can matter for care, even outside cancer.
The reference data has gaps
Most genomes in the world's reference databases come from people of European descent. Indian changes are under-represented, which is why Indian reports carry uncertain results more often.
Being addressed by
- National Indian genome programmes
- Hospital and university studies
- Laboratories sharing their data
Not sure whether this applies to you?
Ask an oncologistFrom clue to confirmation
How would a change be confirmed as an Indian founder change?
It keeps turning up
Laboratories notice the same exact change in many unrelated Indian families, often from one region or community.
The surrounding DNA is checked
If carriers share the same stretch of DNA around the change, it came from one ancestor rather than arising many times.
Healthy people are tested
Researchers measure how common the change is in people without cancer, across communities. That shows where it is concentrated and how much risk it really adds.
A targeted test is validated
Only then can a short, cheaper test be trusted for that community. For India, very few changes have reached this stage.
On your report
The words you will meet, in plain language
- Founder variant
- A change inherited from one early ancestor that is now common in a particular community.
- Recurrent variant
- A change seen in several unrelated families. It may be a founder change, or it may simply arise often.
- Reference database
- A large collection of genomes a laboratory checks your result against, to see how common a change is.
- Variant frequency
- How common a change is in healthy people. A change common in healthy people is less likely to be harmful.
- VUS
- A variant of uncertain significance. The laboratory cannot yet say whether it matters, so it should not guide treatment.
- Research consent
- Your separate permission for your sample or data to be used in studies. Saying no does not affect your care.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What we know, and what we do not yet know
Known
Not yet known
Many Indian communities have strong founder effects
Which of those involve cancer genes
Some BRCA changes recur in Indian families
Whether they trace to Indian founders
Full-gene testing finds founder and private changes
When a validated Indian founder panel will exist
Indian results are more often uncertain
How many will be reclassified, and how soon
Being straight with you
What this page cannot tell you
It cannot tell you whether your caste, community or district carries a cancer founder change. That evidence mostly does not exist yet, and studies so far are small. Anyone who says otherwise with confidence is going beyond what is known. That includes laboratories that market a panel as designed for a particular caste or region. Ask them which published study the panel is based on.
It cannot read a result you are holding
If your report mentions a change seen in other Indian families, that is interesting context but it does not change what the change means for you. What your specific variant means is a question for the counsellor who ordered the test.
Who this does not apply to
Most people do not need a genetic test, and your community is not a reason to have one. What counts is the family history: young diagnoses, several relatives on one side, two cancers in one person, or rare cancers. If none of those apply, a counsellor will usually tell you testing is unlikely to help. That honest answer saves families money and a great deal of worry.
Commonly believed
Four things families tell us, and what is actually true
"There is a special cheaper test for our community's genes."
No validated community-specific cancer panel exists for Indian families yet. A test that checks only a short list could miss your family's change. Full-gene testing remains the standard.
"Founder mutations are a foreign problem."
India has some of the strongest founder effects ever measured. What India lacks is not founder changes but the research to name the ones that matter for cancer.
"An uncertain result means our community has a dangerous gene."
It more often reflects gaps in the reference data. Many uncertain results in Indian patients are later reclassified as harmless once more Indian genomes are studied.
"Taking part in research will expose our community."
Research needs your separate consent, and results are reported without naming individuals. You can say no, and it will not affect your care in any way.
Questions we are asked
Common questions about founder mutations in India
Is there a BRCA founder mutation in Telugu families?
None has been confirmed. Some BRCA changes have been reported more than once in South Indian patients, but the studies are small and have not shown a clear Telugu founder change. Full-gene testing is the right approach for families in Telangana and Andhra Pradesh.
Why is my Indian report more likely to say uncertain?
Laboratories judge a change partly by how common it is in healthy people. Indian genomes are under-represented in the databases they use, so a harmless change common in your community may look rare and be reported as uncertain. It should not change your treatment.
Should I tell the counsellor which community I belong to?
It can help them read your family tree and weigh an uncertain result. It is asked for medical reasons only, and you may decline. Whatever you share is recorded as medical information and kept confidential.
Can I help research on Indian founder changes?
Yes. When you are tested, you may be asked for separate consent for your sample or data to be used in research. Saying yes helps future families get clearer answers. Saying no has no effect on your care. Ask how your data will be stored before you decide.
Would a founder test abroad work for my family?
Probably not. Founder panels used abroad check for the changes common in those communities. An Indian family is unlikely to carry them, so a negative result from such a panel tells you very little. Ask for full-gene testing instead.
Is tumour testing the same thing?
No. Tumour testing looks for changes inside the cancer to guide treatment, and those changes are not inherited. Founder changes are inherited and present in every cell. Tumour testing is explained in our targeted therapy section.
Will my uncertain result be updated as India learns more?
Many laboratories review uncertain results as new evidence arrives, but the process differs between laboratories. Ask before testing whether they will contact you or your doctor if your result is reclassified, and keep your report somewhere you can find it.
Where do I start?
Start with your family history, not your community. Write down who was diagnosed, with what, and at roughly what age, on both sides. Take it to a genetic counsellor or your oncologist, or call the CION helpline and someone will point you to the right clinic.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Nature Genetics — The promise of discovering population-specific disease-associated genes in South Asia
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ) – Health Professional Version
- Genetics in Medicine (ACMG/AMP) — Standards and guidelines for the interpretation of sequence variants
- ClinVar (NCBI) — ClinVar
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Founder mutations explainedHow a founder change spreads, with the best-known examplesEndogamy and community-specific riskWhat marrying within a community does and does not changeVUS in a germline reportWhat to do with an uncertain resultConsent for research useYour choices if you are asked to join a study
Talk to us
Not sure which test suits your family?
Tell us about your family history on both sides. A genetic counsellor will tell you honestly whether a test is worth doing, and which one, in Telugu if you prefer. One helpline serves every CION centre.